Halozyme Therapeutics, Inc. Announces Proposed Offering of $500 Million of Convertible Senior Notes due 2028 August 15, 2022 7:00 am|The Company plans to purchase up to $200 million worth of shares concurrently with, or shortly after, the…
Sentinel Exits Altima Dental via Merger with 123Dentist August 15, 2022 7:00 am|Firm to Remain a Minority Investor
WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2022 RESULTS August 15, 2022 7:00 am|CALGARY, AB AND MOUNTAIN VIEW, CA, Aug. 15, 2022 /PRNewswire/ – Willow Biosciences Inc. (“Willow” or the “Company“)…
Vestar Capital Partners Announces Promotions August 15, 2022 7:00 am|Neil Merchant, Mark Dirzulaitis, and Angela Yun Promoted to Principal; Alex Veronneau Promoted to Vice President
Percheron Capital Announces Partnership with McWilliams & Son, a Leading Provider of Residential HVAC and Plumbing Services August 15, 2022 7:00 am|Investment Supports McWilliams & Son’s Rapid Expansion Through Organic Growth and Strategic Acquisitions in the Growing, Resilient and…
AWH Enters Definitive Agreement Providing the Option to Acquire Ohio Patient Access LLC August 15, 2022 7:00 am|– Option would add three dispensaries, increasing AWH’s footprint in Ohio to five, the maximum permitted in the…
McDermott Awarded Pre-FEED Contract for Proposed H2Perth Project from Woodside Energy August 15, 2022 7:00 am|HOUSTON, Aug. 15, 2022 /PRNewswire/ — McDermott International has been awarded a Pre Front-End Engineering Design (Pre-FEED) contract…
First Mining Provides Update Regarding Acquisition of Duparquet Gold Project August 15, 2022 7:00 am|VANCOUVER, BC, Aug. 15, 2022 /PRNewswire/ – First Mining Gold Corp. (“First Mining” or the “Company”) (TSX: FF) (OTCQX:…
SUN-MAID® FEEDS IMAGINATIONS WITH YOUTUBE ICON MRBEAST AND BEAST PHILANTHROPY FOR BACK-TO-SCHOOL VIDEO August 15, 2022 7:00 am|Iconic Snack Company and Beast Philanthropy – Official Non-Profit to YouTube Star MrBeast – Donate Around $200,000 in…
Genprex Announces Safety Review Committee Approves Dose Escalation in Acclaim-1 Phase 1/2 Trial of REQORSA™ in Combination with Tagrisso® in Non-Small Cell Lung Cancer August 15, 2022 7:00 am|Recommends Advancing Acclaim-1 to Increased Dose in Second Cohort of Phase 1 Portion of Trial